Compound ID | 2851
Class: Small molecule antibacterial agent
Details of activity: | Active against Mycobacterium tuberculosis; cytochrome bc1 inhibitor |
Propensity to select resistant mutants: | Yes, at 3.33x10^-9 mutation frequency at 5xMIC |
Description: | Synthetic compound; thiazole; no macrophage cytotoxicity at 200 uM (highest concentration tested) |
Institute where first reported: | German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany |
Year first mentioned: | 2023 |
Development status: | Experimental |
Chemical structure(s): | |||||||||||
|
|
External links: | |
Citation: | https://journals.asm.org/doi/10.1128/aac.00251-23 |